NFE2L2 and melanoma: The link between KEAP1 loss and altered cytokine expression is supported by interactions between NRF2 and NF-κB14, and our findings in melanoma are consistent with a preliminary report showing that KEAP1 mutations cause resistance to anti-PD1 treatment in a transgenic mouse model of lung cancer20.